Argenx to Buy Forte Biosciences for $2.2 Billion
The deal to acquire the Nasdaq-listed Forte represents a 41% premium to its closing price on Friday.
The Source
TWSJ
Tech
It’s the Deadliest Room in the House—Especially for Seniors
TWSJ·4d ago·3 min read
Business
Kenneth Dart’s Candle Lake Crosses Mandatory Bid Threshold For Sweden’s Evolution
TWSJ·40m ago·3 min read
Tech
Maker of Chips Sought by Apple Soars to No. 1 in China Stock Market
TWSJ·47m ago·3 min read
Business
Vodafone Raises Guidance on Safaricom Deal
TWSJ·1h ago·3 min read
Related
On this beat
Tech
It’s the Deadliest Room in the House—Especially for Seniors
TWSJ·4d ago·3 min read
Tech
Maker of Chips Sought by Apple Soars to No. 1 in China Stock Market
TWSJ·47m ago·3 min read
Tech
God of War Laufey Release Date Announced, Next God of War Game With Kratos Confirmed
GADGETS 360·1h ago·3 min read
Tech
Vivo X300 E Launched With Snapdragon 8 Gen 5 SoC, 7,200mAh Battery: Price, Specifications
GADGETS 360·1h ago·3 min read
